期刊
JOURNAL OF IMMUNOLOGY
卷 164, 期 2, 页码 664-669出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.164.2.664
关键词
-
类别
CTLA-4 (CD152) is thought to be a negative regulator of T cell activation. Little is known about the function of CTLA-4 in Th2-type immune responses. We have investigated the effect of initial treatment with anti-CTLA-4 mAb on murine chronic graft-vs-host disease. Transfer of parental BALB/c splenocytes into C57BL/6 x BALB/c F-1 mice induced serum IgE production, IL-4 expression by donor CD4(+) T cells, and host allo-bg-specific IgG1 production at 6-9 wk after transfer. Treatment with anti-CTLA-4 mAb for the initial 2 wk significantly reduced IgE and IgG1 production and IL-4 expression. Analysis of the splenic phenotype revealed the enhancement of donor T cell expansion, especially. within the CD8 subset, and the elimination of host cells early after anti-CTLA-4 mAb treatment. This treatment did not affect early IFN-gamma expression by CD4(+) and CD8(+) T cells and anti-host cytolytic activity. Thus, blockade of CTLA-4 greatly enhanced CD8(+) T cell expansion, and this may result in the regulation of consequent Th2-mediated humoral immune responses. These findings suggest a new approach for regulating IgE-mediated allergic immune responses by blockade of CTLA-4 during a critical period of Ag sensitization.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据